Loading...

Kuros Biosciences AG

CSBTF•PNK
Healthcare
Biotechnology
$28.00
$0.00(0.00%)
U.S. Market opens in 2h 8m

Kuros Biosciences AG (CSBTF) Stock Overview

Explore Kuros Biosciences AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio528.94
EPS (TTM)$0.08
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$27.93
3 Months$36.64
1 Year Target$53.74

CSBTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kuros Biosciences AG (CSBTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $53.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 528.94 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.54%
3-Month Change
-12.25%
6-Month Change
-22.63%
Year-to-Date (YTD) Change
-26.97%
1-Year Change
-10.91%
3-Year Change
1381.48%
5-Year Change
1214.55%
All-Time (Max) Change
25.96%

Contact Information

https://www.kuros.ch
41 44 733 4747
Wagistrasse 25, Schlieren, NaN, 8952

Company Facts

122 Employees
IPO DateApr 17, 2014
CountryCH
Actively Trading

Frequently Asked Questions